Product NDC: | 39822-0190 |
Proprietary Name: | Acetazolamide |
Non Proprietary Name: | Acetazolamide |
Active Ingredient(s): | 500 mg/1 & nbsp; Acetazolamide |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 39822-0190 |
Labeler Name: | X-GEN Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040784 |
Marketing Category: | ANDA |
Start Marketing Date: | 20081210 |
Package NDC: | 39822-0190-7 |
Package Description: | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (39822-0190-7) |
NDC Code | 39822-0190-7 |
Proprietary Name | Acetazolamide |
Package Description | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (39822-0190-7) |
Product NDC | 39822-0190 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Acetazolamide |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20081210 |
Marketing Category Name | ANDA |
Labeler Name | X-GEN Pharmaceuticals, Inc. |
Substance Name | ACETAZOLAMIDE SODIUM |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient] |